These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 28387542)
1. The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease. Nathan AS; Sen S; Yeh RW Expert Opin Drug Saf; 2017 May; 16(5):561-572. PubMed ID: 28387542 [TBL] [Abstract][Full Text] [Related]
2. Updates in antiplatelet agents used in cardiovascular diseases. Cheng JW J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):514-24. PubMed ID: 24213473 [TBL] [Abstract][Full Text] [Related]
3. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome. Packard KA; Campbell JA; Knezevich JT; Davis EM Pharmacotherapy; 2012 Mar; 32(3):244-73. PubMed ID: 22392457 [TBL] [Abstract][Full Text] [Related]
4. Current and future antiplatelet therapies: emphasis on preserving haemostasis. McFadyen JD; Schaff M; Peter K Nat Rev Cardiol; 2018 Mar; 15(3):181-191. PubMed ID: 29297508 [TBL] [Abstract][Full Text] [Related]
5. Platelet Function Testing: A Role for Personalised Therapy in Coronary Disease. Farag M; Gorog DA Curr Pharm Des; 2017; 23(9):1315-1327. PubMed ID: 28137225 [TBL] [Abstract][Full Text] [Related]
6. The use of platelet reactivity testing in patients on antiplatelet therapy for prediction of bleeding events after cardiac surgery. Leunissen TC; Janssen PW; Ten Berg JM; Moll FL; Korporaal SJ; de Borst GJ; Pasterkamp G; Urbanus RT Vascul Pharmacol; 2016 Feb; 77():19-27. PubMed ID: 26724555 [TBL] [Abstract][Full Text] [Related]
8. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices. Faxon DP Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effect of aspirin in patients with coronary artery disease. Grove EL Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204 [TBL] [Abstract][Full Text] [Related]
12. Update on aspirin in the treatment and prevention of cardiovascular disease. Hennekens CH Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736 [TBL] [Abstract][Full Text] [Related]
14. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379 [TBL] [Abstract][Full Text] [Related]
15. Preventing serious sequelae after an acute coronary syndrome: the consequences of thrombosis versus bleeding with antiplatelet therapy. Islam AM; Patel PM J Cardiovasc Pharmacol; 2010 Jun; 55(6):585-94. PubMed ID: 20224426 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet agents in hemodialysis. Migliori M; Cantaluppi V; Scatena A; Panichi V J Nephrol; 2017 Jun; 30(3):373-383. PubMed ID: 27928736 [TBL] [Abstract][Full Text] [Related]
17. Ticagrelor: a review of its use in adults with acute coronary syndromes. Dhillon S Am J Cardiovasc Drugs; 2015 Feb; 15(1):51-68. PubMed ID: 25672642 [TBL] [Abstract][Full Text] [Related]